Navigation Links
Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
Date:8/5/2008

artnerships with companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich and several companies applying its ZFP Technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release may contain forward-looking statements based on Sangamo's current expectations. These forward-looking statements include, without limitation, references to the research and development of novel ZFP TFs and ZFNs as ZFP Therapeutics, applications of Sangamo's ZFP TF technology platform, strategic partnerships with collaborators and clinical trials of ZFP Therapeutics. Actual results may differ materially from these forward-looking statements due to a number of factors, including technological challenges, uncertainties relating to the initiation and completion of stages of ZFP Therapeutic clinical trials, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See the company's SEC filings, and in particular, the risk factors described in the company's Annual Report on Form 10-K and its most recent Quarterly Report on Form 10-Q. Sangamo BioSciences, Inc. assumes no obligation to update the forward-looking information contained in this press release.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
2. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
3. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
4. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
5. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
7. Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
8. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
9. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
10. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
11. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2Hard To Treat Diseases 28HTDS 29 to Retire Regulation D 504 Offering 56205 1Hard To Treat Diseases 28HTDS 29 to Retire Regulation D 504 Offering 56205 2Hard To Treat Diseases 28HTDS 29 to Retire Regulation D 504 Offering 56205 3Aflac Incorporated To Present at the Keefe Bruyette 26 Woods 2009 Insurance Conference 56203 1Aflac Incorporated To Present at the Keefe Bruyette 26 Woods 2009 Insurance Conference 56203 2Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 1Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 2Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 3Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 4Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 5Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 6Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 7Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 8Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 9Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 10Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 11Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 12Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 13Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 14Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 15Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 16Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 17Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 18Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 19Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 20Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 21